Keywords: new, foradil, formulation, entering, phase, iii, novartis

New Foradil formulation entering Phase III

Article | 08 February 2001

Print This

Novartis has started Phase III trials in Europe for a new dry powderinhaler formulation of its long-acting beta agonist Foradil ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in